Jennifer Nogueira Coelho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jennifer Nogueira Coelho has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Adriana Castello Costa Girardi
Universidade de São Paulo
1 shared publication Andreia Boaro
Universidade de São Paulo
1 shared publicationAndrey J. Serra
Federal University of São Paulo
1 shared publication- Autumn Nourse Harris
North Carolina State University
1 shared publication - Danúbia Silva dos Santos
Universidade de São Paulo
1 shared publication Ednei L. Antonio
Federal University of São Paulo
1 shared publication
Latest Publications
- Open Access
- 1 June 2026
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 330 (6) , C1775-C1787
Empagliflozin targets a renal neuro-epithelial-immune axis in heart failure
Our findings identify a renal neuro-epithelial-immune axis that may, at least in part, underlie empagliflozin-mediated renoprotection in heart failure. Empagliflozin selectively attenuated surrogate markers of renal sympathetic activity, lowering cortical and urinary norepinephrine without detectable changes in intrarenal renin-angiotensin system components. These changes were accompanied by a shift toward a reparative macrophage phenotype. In vitro, empagliflozin blocked norepinephrine-induced SGLT2 upregulation and IL-6 production, linking sympathetic signaling to tubular inflammation.
- 1 June 2026
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 330 (6) , C1775-C1787
Open AccessEmpagliflozin targets a renal neuro-epithelial-immune axis in heart failure
Our findings identify a renal neuro-epithelial-immune axis that may, at least in part, underlie empagliflozin-mediated renoprotection in heart failure. Empagliflozin selectively attenuated surrogate markers of renal sympathetic activity, lowering cortical and urinary norepinephrine without detectable changes in intrarenal renin-angiotensin system components. These changes were accompanied by a shift toward a reparative macrophage phenotype. In vitro, empagliflozin blocked norepinephrine-induced SGLT2 upregulation and IL-6 production, linking sympathetic signaling to tubular inflammation.
- 1 November 2025
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 329 (5) , F615-F626
Sex differences in renal acid-base regulation
Disturbances in acid-base regulation are common and can have detrimental effects. Here, we provide evidence that acid-base disturbances in males and females are consistent with female mice being able to defend acid and base challenges more effectively. Our data have potential clinical importance in humans regarding the treatment of acidosis and alkalosis in males versus females.
- 1 November 2025
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 329 (5) , F615-F626
Sex differences in renal acid-base regulation
Disturbances in acid-base regulation are common and can have detrimental effects. Here, we provide evidence that acid-base disturbances in males and females are consistent with female mice being able to defend acid and base challenges more effectively. Our data have potential clinical importance in humans regarding the treatment of acidosis and alkalosis in males versus females.